Abstract
Beta thalassemia minor (BTM) is a hereditary disease caused by defective globin synthesis and it is frequently asymptomatic or only mildly anemic. Female sexual dysfunction affects 21–41% of women worldwide. In this study we aimed to investigate female sexual dysfunction in subjects with BTM. A total of 183 subjects who had regular sexual intercourse with marital partners were enrolled in this cross-sectional study. The study group was comprised of 87 subjects with BTM and the control group included 96 healthy subjects. Hemoglobin electrophoresis were performed in all subjects, and all participants were assessed by the Female Sexual Function Index (FSFI) questionnaire and the Arizona Sexual Experience Scale (ASEX). The FSFI scores of the study group were significantly lower than in the control group (19.1 ± 9.6 vs. 25.2 ± 6.6, p < 0.001). Conversely, the ASEX scores of the study group were higher than in the control group (15.2 ± 41 vs. 13.5 ± 6.1, p = 0.0085). Sexual functions were poor in subjects with BTM in this study and we conclude that certain metabolic diseases associated with BTM, such as insulin resistance, hyperglycemia and dyslipidemia, may be the main causes of sexual dysfunctions in these subjects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;21:5–11.
Kalleas C, Anagnostopoulos K, Sinopoulou K, Delaki E, Margaritis D, Bourikas G, et al. Phenotype and genotype frequency of beta-thalassemia and sickle cell disease carriers in Halkidiki, Northern Greece. Hemoglobin. 2012;36:64–72.
World Health Organization. Sexual and reproductive health, working definitions. http://www.who.int/reproductivehealth/topics/sexual_health/sh_definitions/en/. Accessed 11 Jul 2019.
McCool ME, Zuelke A, Theurich MA, Knuettel H, Ricci C, Apfelbacher C. Prevalence of female sexual dysfunction among premenopausal women: a systematic review and meta-analysis of observational studies. Sex Med Rev. 2016;4:197–212.
Erol B, Tefekli A, Sanli O, Ziylan O, Armagan A, Kendirci M, et al. Does sexual dysfunction correlate with deterioration of somatic sensory system in diabetic women? Int J Impot Res. 2003;15:198–202.
Pontiroli AE, Cortelazzi D, Morabito A. Female sexual dysfunction and diabetes: a systematic review and metaanalysis. J Sex Med. 2013;10:1044–51.
Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, Okopień B. Sexual functioning and depressive symptoms in women with diabetes and prediabetes receiving metformin therapy: a pilot study. Exp Clin Endocrinol Diabetes. 2017;125:42–8.
Maseroli E, Scavello I, Vignozzi L. Cardiometabolic risk and female sexuality-Part I. Risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes. Sex Med Rev. 2018;6:508–24. https://doi.org/10.1016/j.sxmr.2018.02.009.
Duncan LE, Lewis C, Jenkins P, Pearson TA. Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens. 2000;13:640–7.
Baldassarre M, Alvisi S, Mancini I, Moscatiello S, Marchesini G, Seracchioli R, et al. Impaired lipid profile is a risk factor for the development of sexual dysfunction in women. J Sex Med. 2016;13:46–54.
Gozashti MH, Hasanzadeh A, Mashrouteh M. Prevalence of metabolic syndrome in patients with minor beta thalassemia and its related factors: a cross-sectional study. J Diabetes Metab Disord. 2014;13:108.
Kırım S, Keşkek ŞÖ, Turhan A, Saler T. Is β-thalassaemia minor associated with metabolic disorder? Med Princ Pract. 2014;23:421–5.
Rosen C, Brown J, Heiman S, Leiblum C, Meston R, Shabsigh D, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208.
McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26:25–40.
Aygin D, Eti Aslan F. The Turkish adaptation of The Female Sexual Function Index, Turkey clinics. J Med. 2005;25:393–9.
Soykan A. The reliability and validity of Arizona sexual experiences scale in Turkish ESRD patients undergoing hemodialysis. Int J Impot Res. 2004;16:531–4. https://doi.org/10.1038/sj.ijir.3901249.
Biddle AK, West SL, D’Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden. Value Health. 2009;12:763–72.
Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2005;17:39–57.
Keşkek SO, Kirim S, Turhan A, Turhan FG. Depression in subjects with beta-thalassemia minor. Ann Hematol. 2013;92:1611–5.
Ozturk S, Sut HK, Kucuk L. Examination of sexual functions and depressive symptoms among infertile and fertile women. Pak J Med Sci. 2019;35:1355–60.
Tong Peter CY, Ng Maggie CY, Ho Vhung S, So Wing Y, Li June KY, Lam Chris WK, et al. C-reactive protein and Insulin resistance in subject with thalassemia minor and a family history of diabetes. Diabetes Care. 2002;25:1480–1.
Zsoldos M, Pajor A, Pusztafalvi H. [Relation between sexual dysfunction and metabolic syndrome]. Orv Hetil. 2019;160:98–103.
Maseroli E, Fanni E, Cipriani S, Scavello I, Pampaloni F, Battaglia C, et al. Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance. J Sex Med. 2016;13:1651–61.
Ozcan S, Sahin Nevin H, Bilgic D, Yilmaz Sema D. Is sexual dysfunction associated with diabetes control and related factors in women with diabetes. Sex Disabil. 2011;29:251–61.
Esposito K, Maiorino MI, Bellastella G, Giugliano F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res. 2010;22:179–84.
Kizilay F, Gali HE, Serefoglu EC. Diabetes and sexuality. Sex Med Rev. 2017;5:45–51. https://doi.org/10.1016/j.sxmr.2016.07.002.
Kolodny RC. Sexual dysfunction in diabetic females. Diabetes. 1971;20:557–9.
Von Bibra H, Saha S, Hapfelmeier A, Müller G, Schwarz PEH. Impact of the triglyceride/high-density lipoprotein cholesterol ratio and the hypertriglyceremic-waist phenotype to predict the metabolic syndrome and insulin resistance. Horm Metab Res. 2017;49:542–9.
Esposito K, Ciotola M, Maiorino MI, Giugliano F, Autorino R, De Sio M, et al. Hyperlipidemia and sexual function in premenopausal women. J Sex Med. 2009;6:1696–703.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Keşkek, Ş.Ö., Demirtaş, D., Uysal, G. et al. Sexual dysfunction in female subjects with beta-thalassemia minor. Int J Impot Res 32, 358–362 (2020). https://doi.org/10.1038/s41443-020-0283-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41443-020-0283-z